TriangleHEALTH PROFESSIONAL · SOURCE READING
Key References for Primary Central Nervous System Lymphoma Treatment
Source: Primary Central Nervous System Lymphoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: May 13, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
These references have been identified by members of the PDQ Adult Treatment Editorial Board as significant in the field of primary central nervous system (CNS) lymphoma treatment. This list is provided to inform users of important studies that have helped shape the current understanding of and treatment options for primary CNS lymphoma. Listed after each reference are the sections within this summary where the reference is cited.
Source links and citations
Ferreri AJ, Illerhaus G: The role of autologous stem cell transplantation in primary central nervous system lymphoma. Blood 127 (13): 1642-9, 2016. [PUBMED Abstract]Cited in:
Source links and citations
Ferreri AJ, Illerhaus G: The role of autologous stem cell transplantation in primary central nervous system lymphoma. Blood 127 (13): 1642-9, 2016. [PUBMED Abstract]Cited in:
Treatment of Primary CNS Lymphoma.
Source links and citations
Korfel A, Thiel E, Martus P, et al.: Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma. Neurology 84 (12): 1242-8, 2015. [PUBMED Abstract]Cited in:
Source links and citations
Korfel A, Thiel E, Martus P, et al.: Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma. Neurology 84 (12): 1242-8, 2015. [PUBMED Abstract]Cited in:
Treatment of Primary CNS Lymphoma.
Source links and citations
Korfel A, Thiel E, Martus P, et al.: Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma. Neurology 84 (12): 1242-8, 2015. [PUBMED Abstract]Cited in:
Treatment of Intraocular Lymphoma.
Source links and citations
Thiel E, Korfel A, Martus P, et al.: High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncol 11 (11): 1036-47, 2010. [PUBMED Abstract]Cited in:
Source links and citations
Thiel E, Korfel A, Martus P, et al.: High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncol 11 (11): 1036-47, 2010. [PUBMED Abstract]Cited in:
Treatment of Primary CNS Lymphoma.
Source links and citations
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice